Boston BioBreak – Events Archive
Please see below for attendees and images from this event.
Boston
Boston BioBreak Networking Happy Hour- March 22nd, 2018
March 22, 2018
5:30-7:30 pm
Attendees at this event
| Geoff Meyerson | Locust Walk |
| Jamil Beg | 5AM Ventures |
| Peter Lanciano | Periphagen Inc. |
| Jay Mohr | Dirigo Therapeutics |
| Jordan Leef | Pyramid Biosciences Inc |
| Donald Fishbein | Evolve Therapeutics |
| Imran Eba | Action Potential Venture Capital |
| Brian Gallagher | Abingworth |
| Imran Nasrullah | Boehringer-Ingelheim |
| Greg Miller | Visterra |
| Brad Prosek | Constellation Pharmaceuticals |
| Yukari Perrella | Yuma Therapeutics |
| Kleem Chaudhary | Biogen |
| Marcelo Cheresky | Bioverativ |
| Paul Conrad | Bluebird Bio |
| Douglas MacDougall | MacDougall Biomedical Communications |
| Catherine Thut | Novartis Institutes for BioMedical Research |
| Bonnie Fendrock | Cyta Therapeutics |
| Brad Carver | SynDevRx |
| John Hennessy | Palleon Pharmaceuticals Inc |
| Rick Lundberg | Navitor Pharmaceuticals |
| Bob Silverman | Roche |
| Paul Juniewicz | Takeda Oncology |
| Alan Kugler | Coastal Pharma Group |
| Eric Elenko | PureTech Ventures |
| Jonathan Behr | JDRF T1D Fund |
| Christine Bunt | 20/20 Health Care Partners |
| Michal Preminger | Harvard University |
| David Brush | Novartis Institutes for BioMedical Research |
| Caleb Moore | Acceleron Pharma |
| Gordon Jamieson | Translational Therapeutics |
| Kathryn Gregory | Seneb BioSciences, Inc. |
| Barbara Fox | Tilos Therapeutics |
| Laurence Reid | Warp Drive Bio |
| Mark Fraga | Shire |
| John Dunlop | Amgen |
| Steven Tregay | FORMA Therapeutics |
| Avi Spier | Novartis |
| John Schwartz | AcuityBio |
| Jeff Imbaro | Semma Therapeutics |
| Ed Mascioli | EMMD LLC |
| Arthur Hiller | Antyllus Therapeutics |
| Scott Edwards | SciFluor Life Sciences |
| Markus Haeberlein | Alkermes |
| Martin Williams | Yuma Therapeutics Corp |
| Marian Nakada | J&J |
| Geoffrey Horwitz | Decibel Therapeutics |
| Grant Zimmermann | Harvard University |
| Andy Meyerson | Locust Walk |
| Brendan Downey | Takeda |
| Michael Boretti | Epizyme |
| Ryan Dietz | Boston Children's Hospital |
| John Tagliamonte | WntRx |
| John Delyani | Tmunity |
| Tariq Kassum | Obsidian |
| Chuck Kunsch | AbbVie Ventures |
| Neil Swami | MVM Life Sciences Partners |
| Martin Heidecker | Boehringer Ingelheim Venture Fund |
| James Shanahan | SynDevRx, Inc. |
| Alexander Pickett | Mediqventures, Ltd. |
| Rich Howlett | Keros Therapeutics |
| Bob Palladino | Bionevia LLC |
| Josh Hamermesh | Gamida Cell |
| Catherine Sohn | Jazz Pharmaceuticals |
| Tom Fitzgerald | Velico Medical, Inc. |
| Lizabeth Leveille | Merck |
| Laura Sepp-Lorenzino | Vertex Pharmaceuticals |
| Ailis Tweed-Kent | Cocoon Biotech |
| David Standring | |
| Brian Hess | LaunchPad Medical |
| Anupama Ahuja | Children's TIDO |
| Mustafa Noor | Genevant Sciences |
| Maude Tessier | Kyn Therapeutics |
| Roman Fleck | Janpix |
| Stephen Potter | AGTC |
| Neal Farber | NEUROHEALING PHARMACEUTICALS |
| Derek Yoon | AJU IB Investment |
| Patrick Tricoli | NANOBIOTIX US |
| Chris Primiano | Karyopharm Therapeutics |
| Andrew meadow | Excelyrate Capital |
| Kyle Meetze | EdenRoc Sciences |
| Fumitaka Mori | Remiges Ventures |
| Michael Magliochetti | Riverside Partners |
| Tarik Soliman | Extend Biosciences |
| Joel Batson | RA Capital Management |
| Chris Gemmiti | Sentien Biotech |
| Jennifer Wheler | TScan Therapeutics |
| Phillip Samayoa | Atlas Ventures |
| Catherine Nuccio | Alexandria Venture Investments |
| Remis Bistras | ThermoPharma |
| Shaan Gandhi | Longwood Fund |
| Weijie Poh | PathoVax |
| Christopher Scannell | Akrivis |
| Stephen Curtis | MPM Capital |
| Anh Hoang | Sofregen Medical |
| Daniel Macaya | RA capital |
| Ted Marple | Acworth Pharmaceuticals, Inc. |
| David Sherris | GenAdam Therapeutics |
| Joel BERNIAC | Akrivis Technologies |
| Meredith Fisher | Partners Innovation Fund |
| Bruce Beutel | SQZ Biotech |
| Amanda Kay | Synlogic |
| Hhilippe Mauberna | Nanobiotix |
| Kollol Pal | Pyramid Biosciences |
| Laurent Levy | Nanobiotix |
| Connor Duffy | Draper Nexus Ventures |
| Patrice Milos | Medley Genomics |
| Kevin Mills | Cyteir Therapeutics, Inc |
| Edwin Holland | Cenoxsys, LLC |
| Yury Kukushkin | 4biocapital |
| Kate Rumrill | NeoSync, Inc. |
| Gary Fletcher | RnDDx Solutions LLC |
| Peng Leong | Novogen |
| John M Sorvillo | ReForm Biologics |
| Stefano Gulla | Abcuro |
| Howard Kim | Asahi Kasei |
| Maria Zlyhastseva | BioBreak |
| David Raiser | Aldatu Biosciences |
| Jennifer King | Intellia Therapeutics |
| Kevin Pong | Anima Biotech |
| Alan Ginsberg | Shire |
| Ram Aiyar | Corvidia Therapeutics |
| Anthony Walsh | BioInnovation Capital |
| Bryan Lord | Orthopedic Venture Partners |
| Bill Whelan | Mintz Levin |
| Laura Stoppel | RA Capital Management |
| Meg Krench | RA Capital Management |
| William Korinek | Astrocyte Pharmaceuticals |
| Adi Mashiach | Mesia Ventures |
| Michael Dudley | TransCode Therapeutics, Inc. |
| Wendy Nelson | Boston Biotech Forum |
| Eric Evans | Mass Medical Angels |
| Evan Thompson | Abcuro |
| Daniel Seto | SternAegis Ventures |
| Komal Joshi | Jounce Therapeutics |
| Jack Leonard | Acworth Pharmaceuticals, Inc |
| VIPULA TAILOR | Azure8 |
| Vito Palombella | Surface Oncology |
| Larry Cai | Fosun |
| Jason Ruth | 5AM Ventures |
| Kathryn McCabe | Eli Lilly |
| Nevin M. Summers | MIT Synthetic Biology Center |
| Benjamin Sigel | Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
| Kerrie Brady | Cetrexion Therapeutics |
| Victor Shifrin | ImmunoChem Therapeutics |
| Joep Muijrers | LSP Life Sciences Partners |
| Joseph Lobacki | Crestovo LLC |
| Jin Ji | PulchriBio |
| Arkesh Mehta | OncoBindi Therapeutics |
| Thomas Leggett | Axcella Health |
| Sophie de Boer | Flagship Pioneering |
| Julien Pham | Genprex |
| Reza Mazhari | Novartis Institutes for BioMedical Research |
| Maria Palasis | 480 Biomedical, Inc. |
| John Dellapa | Mintz Levin |
| Anna French | Qiming Venture US |
| Rosy Hu | Partners Innovation Fund |
| Laszlo Kiss | Pfizer |
| Isabella Zhang | JDRF T1D Fund |
| Melissa BradfordKlug | Keryx |
| Brian DeSchuytner | TESARO |
| Erika Bechtold | Sofregen Medical |
| James Jogerst | Berg Health |
| Adam Buckley | VBI Vaccines Inc |
| Ravneesh Sachdev | Bioverativ |
| Kathryn McAllister | Merck |
| Fred Chereau | LogicBio |
| Rakhshita Dhar | Roche |
| Seiji Nakano | Asahi Kasei - Healthcare |
| John Parker | Springhood Ventures |
| Kyle Dempsey | MVM Partners |
| Frank Haluska | BioCanCell |
| Magdalene Moran | Hydra Biosciences |
| Angelo Moesslang | InGeneron |
| Andrew Gengos | Synlogic |
| Mark Barrett | Frazier Healthcare |
| Marc Schwabish | Fusion Pharma |
| Yoshiaki Kato | Kissei America Inc. |
| Martin Tolar | Alzheon |
| Paul Jaminet | Angiex Inc |
| Mark Charest | Phenomic Capital |
| Joerg Holenz | GSK |
| Albert Hsia | Merck |
| Alex Ray | Boston Millennia Partners |
| Sabrina Yang | Flagship Pioneering |
| Ben Davis | AngioDynamics |
| Thomas Collet | Phrixus Pharmaceuticals, Inc. |
| Timothy Salmon | Socium Therapeutics, Inc. |
| Theonie Anastassiadis | Flagship Pioneering |
| Luba Greenwood | |
| Benjamin Kreitman | Broadview Ventures |
| Tiffany Yu | F-Prime Capital |
| Alan Kriz | Bayer US |
| Mike Luther | Bantam Pharmaceutical, LLC |
| Rene Castro | Foundation Medicine |
| Jeanne Bertonis | Visgo |
| David Tabaczynski | Phion Therapeutics Limited |
| Baruch Harris | Metera |
| Rooz Riahi | RA Capital |
| Christopher Gagliardi | Sanofi Ventures |
| Oliver Dodd | Remora Therapeutics |
| Melissa McCracken | Third Rock Ventures |
| Rajeev Chillakuru | Elstar Therapeutics, Inc |
Photo Gallery for this event
Click any image to view slideshow
(no images found)
Become a Supporter
For more information about sponsorship, please email us at sponsorship@biobreak.org.
